Dr. Martin Tom, MD

Dr. Tom practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Tom's NPI, 1922486430, was assigned on May 16, 2015. Dr. Tom graduated from UTMB Health in 2015. Dr. Tom holds Texas license T7062.

Dr. Tom's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Tom's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tom practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Tom's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Tom is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Tom's licenses on file in 11 states: Texas, Georgia, Mississippi, Oklahoma, Alabama, Arizona, Louisiana, Tennessee, Washington, Florida and Ohio.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Tom treats.

CMS data shows 1,462 Medicare services from Dr. Tom across 15 procedure codes in 2024, for 165 Medicare patients. Medicare paid $114,950 for them.

CMS counts 165 Medicare patients who saw Dr. Tom in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high blood pressure, and 71% have cancer. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tom's median patient age at 69, with 45% women.

In 2024, Dr. Tom wrote 24 Medicare Part D claims for 16 patients. 100% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $218 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Tom for performance year 2024, reported as part of a group. Dr. Tom accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tom as offering telehealth.

Dmand AI links 55 papers to Dr. Tom, published from 2014 to 2025. 2021 was the busiest year, with 11. The most frequent topics are Brain Neoplasms, Radiosurgery and Glioma. Dr. Tom has published most often in Int J Radiat Oncol Biol Phys. Dr. Tom's most frequent co-authors are Rupesh Rajesh Kotecha, MD, Minesh P. Mehta, MD and Manmeet Singh Ahluwalia, MD.

Dmand AI links Dr. Tom to 1 clinical trial. Conditions studied include Brain Neoplasms and Central Nervous System Neoplasms.

CMS Open Payments shows 7 general payments to Dr. Tom from 4 drug and device companies from 2021 to 2024. Consulting fees make up the largest share, 78% of the total. Viewray Technologies Inc paid the most, $8,400.

Dmand AI lists 1 award for Dr. Tom.

Dr. Tom graduated from UTMB Health in 2015.

Dr. Tom is in network with 6 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.